# Spectral Medical Inc. (EDT.TO) fundamentals

Data as of 2026-09-08. TSX, Canada. Sector: Healthcare / Biotechnology. Price C$1.26, market value C$370 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Spectral Medical Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 144.0×**. Each dollar of revenue is priced at 144.0×, a level that requires very high margins or very fast growth to justify.
- **Free-cash-flow yield: -2.8%** (5-yr avg -8.9%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Gross margin: -94.8%**. Spectral Medical Inc. keeps -94.8% of revenue after the direct cost of what it sells, a thin margin typical of retail, distribution and commodity businesses.
- **Operating margin: -431.1%**. Operating margin is negative: the business loses money before interest and tax.
- **Return on equity: 68.4%**. A 68.4% return on equity is extremely high; check whether buybacks or debt have shrunk the equity base, which flatters the ratio.
- **Return on invested capital: 16.6%**. Return on all capital, debt included, is 16.6%: comfortably above what that capital costs.

## Growth
- **Revenue growth (1 yr): 6.8%** (3-yr 13.6%/yr, 5-yr 3.1%/yr). Revenue grew 6.8% over the last year, against 3.1% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): -210.2%**. Earnings per share fell 210.2%, slower than revenue, so margins compressed.

## Financial health
- **Net debt / EBITDA: net cash**. Spectral Medical Inc. holds more cash than debt.
- **Interest coverage: -1.8×**. Operating profit covers interest only -1.8×: fragile.
- **Current ratio: 0.08** (quick 0.07). Current liabilities exceed current assets, so the company depends on ongoing cash generation or refinancing to pay the next year's bills.
- **Altman Z-score: -30.99**. A Z-score of -30.99 is in the distress zone, a signal to examine the balance sheet closely.
- **Piotroski F-score: 1/9**. 1 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. Spectral Medical Inc. does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): -20.8%** (YTD -12.5%, 3-mo -8.7%). The shares are down 20.8% over twelve months including dividends.
- **From 52-week high: -28.4%** (4.1% above the low). Trading 28% below its 52-week high.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 33**. An RSI of 33 is neutral.
- **Beta (1 yr): 0.69** (volatility 40%). Beta of 0.69 against the S&P/TSX Composite: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=EDT.TO · Page: https://foliofundamentals.com/stocks/edt.to

Not investment advice.